What’s Going On At Evestra

Read selected news articles about Evestra, our ongoing work, and our future projects.

Evestra Awarded Department of Defense Grant

Evestra, Inc. has received a grant from the Department of Defense (DoD) to develop a novel first-in-class LIF (Leukemia Inhibitory Factory) to treat triple negative breast cancer (TNBC). The grant proposal, entitled “Targeted Inhibition of…